These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 30447407)

  • 1. Bridging the gap between vaccination with Bacille Calmette-Guérin (BCG) and immunological tolerance: the cases of type 1 diabetes and multiple sclerosis.
    Ristori G; Faustman D; Matarese G; Romano S; Salvetti M
    Curr Opin Immunol; 2018 Dec; 55():89-96. PubMed ID: 30447407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TNF, TNF inducers, and TNFR2 agonists: A new path to type 1 diabetes treatment.
    Faustman DL
    Diabetes Metab Res Rev; 2018 Jan; 34(1):. PubMed ID: 28843039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefits of BCG-induced metabolic switch from oxidative phosphorylation to aerobic glycolysis in autoimmune and nervous system diseases.
    Faustman DL
    J Intern Med; 2020 Dec; 288(6):641-650. PubMed ID: 32107806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neonatal Bacille Calmette-Guerin vaccination and type 1 diabetes.
    Huppmann M; Baumgarten A; Ziegler AG; Bonifacio E
    Diabetes Care; 2005 May; 28(5):1204-6. PubMed ID: 15855590
    [No Abstract]   [Full Text] [Related]  

  • 5. Bacille Calmette-Guérin/DNAhsp65 prime-boost is protective against diabetes in non-obese diabetic mice but not in the streptozotocin model of type 1 diabetes.
    da Rosa LC; Chiuso-Minicucci F; Zorzella-Pezavento SF; França TG; Ishikawa LL; Colavite PM; Balbino B; Tavares LC; Silva CL; Marques C; Ikoma MR; Sartori A
    Clin Exp Immunol; 2013 Sep; 173(3):430-7. PubMed ID: 23692306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacille Calmette Guerin (BCG) and prevention of types 1 and 2 diabetes: Results of two observational studies.
    Dias HF; Mochizuki Y; Kühtreiber WM; Takahashi H; Zheng H; Faustman DL
    PLoS One; 2023; 18(1):e0276423. PubMed ID: 36662841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interplay between bacillus Calmette-Guérin and Treg cells and its role to prevent or cure inflammatory diseases.
    Lagranderie M; Guyonvarc'h PM
    Expert Rev Clin Immunol; 2014 Jun; 10(6):741-5. PubMed ID: 24837545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCG Therapy for Type 1 Diabetes: Restoration of Balanced Immunity and Metabolism.
    Kühtreiber WM; Faustman DL
    Trends Endocrinol Metab; 2019 Feb; 30(2):80-92. PubMed ID: 30600132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BCG therapy is associated with long-term, durable induction of Treg signature genes by epigenetic modulation.
    Keefe RC; Takahashi H; Tran L; Nelson K; Ng N; Kühtreiber WM; Faustman DL
    Sci Rep; 2021 Jul; 11(1):14933. PubMed ID: 34294806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of antimycobacterial Th1-cell responses by a Mycobacterium bovis BCG prime-protein boost vaccination strategy.
    Lu M; Xia ZY; Bao L
    Cell Immunol; 2013; 285(1-2):111-7. PubMed ID: 24177251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide microarray-based characterization of antibody responses to host proteins after bacille Calmette-Guérin vaccination.
    Valentini D; Rao M; Rane L; Rahman S; Axelsson-Robertson R; Heuchel R; Löhr M; Hoft D; Brighenti S; Zumla A; Maeurer M
    Int J Infect Dis; 2017 Mar; 56():140-154. PubMed ID: 28161459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proposing BCG Vaccination for
    Dow CT
    Microorganisms; 2020 Feb; 8(2):. PubMed ID: 32033287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential health effects from non-specific stimulation of the immune function in early age: the example of BCG vaccination.
    Rousseau MC; Parent ME; St-Pierre Y
    Pediatr Allergy Immunol; 2008 Aug; 19(5):438-48. PubMed ID: 18167158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prime-boost vaccination with Bacillus Calmette Guerin and a recombinant adenovirus co-expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis induces robust antigen-specific immune responses in mice.
    Li W; Li M; Deng G; Zhao L; Liu X; Wang Y
    Mol Med Rep; 2015 Aug; 12(2):3073-80. PubMed ID: 25962477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic cells induce CD4+ and CD8+ T-cell responses to Mycobacterium bovis and M. avium antigens in Bacille Calmette Guérin vaccinated and nonvaccinated cattle.
    Hope JC; Kwong LS; Sopp P; Collins RA; Howard CJ
    Scand J Immunol; 2000 Sep; 52(3):285-91. PubMed ID: 10972905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunisation and type 1 diabetes mellitus: is there a link?
    Hiltunen M; Lönnrot M; Hyöty H
    Drug Saf; 1999 Mar; 20(3):207-12. PubMed ID: 10221850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of bacille Calmette-Guérin vaccination at birth on immune response in China.
    Pang Y; Kang W; Zhao A; Liu G; Du W; Xu M; Wang G; Zhao Y; Zheng S
    Vaccine; 2015 Jan; 33(1):209-13. PubMed ID: 25454854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can immunization with Bacillus Calmette-Guérin (BCG) protect against Alzheimer's disease?
    Gofrit ON; Bercovier H; Klein BY; Cohen IR; Ben-Hur T; Greenblatt CL
    Med Hypotheses; 2019 Feb; 123():95-97. PubMed ID: 30696606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proof-of-concept, randomized, controlled clinical trial of Bacillus-Calmette-Guerin for treatment of long-term type 1 diabetes.
    Faustman DL; Wang L; Okubo Y; Burger D; Ban L; Man G; Zheng H; Schoenfeld D; Pompei R; Avruch J; Nathan DM
    PLoS One; 2012; 7(8):e41756. PubMed ID: 22905105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Newborn BCG vaccination complemented by boosting correlates better with reduced juvenile diabetes in females, than vaccination alone.
    Klein BY
    Vaccine; 2020 Sep; 38(41):6427-6434. PubMed ID: 32773242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.